Back

Native and engineered human megakaryocytic extracellular vesicles for targeted non-viral cargo delivery to blood stem cells

Das, S.; Thompson, W.; PAPOUTSAKIS, E. T.

2023-04-12 bioengineering
10.1101/2023.04.11.536479 bioRxiv
Show abstract

Native and engineered extracellular vesicles (EVs) generated from human megakaryocytes (huMkEVs) or from the human megakaryocytic cell line CHRF (CHEVs) interact with tropism delivering their cargo to both human and murine hematopoietic stem and progenitor cells (HSPCs). 24 hours after intravenous infusion of huMkMPs into NOD-scid IL2R{gamma}null (NSG) mice, they induced a nearly 50% increase in murine platelet counts relative to saline control, thus demonstrating the potential of these EVs, which can be stored frozen, for treating thrombocytopenias. PKH26-labeled huMkMPs or CHEVs localized to the HSPC-rich bone marrow preferentially interacting with murine HSPCs. Using engineered huMkEVs or CHEVs, their receptor-mediated tropism for HSPCs was explored to functionally deliver synthetic cargo, notably plasmid DNA coding for a fluorescent reporter, to murine HSPCs both in vitro and in vivo. These data demonstrate the potential of these EVs as a non-viral, HSPC-specific cargo vehicle for gene therapy applications to treat hematological diseases. Native and engineered human megakaryocytic extracellular vesicles for targeted non-viral cargo delivery to blood stem cells (Table of Contents): O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=111 SRC="FIGDIR/small/536479v1_ufig1.gif" ALT="Figure 1"> View larger version (49K): org.highwire.dtl.DTLVardef@664768org.highwire.dtl.DTLVardef@d9fe13org.highwire.dtl.DTLVardef@1b795eforg.highwire.dtl.DTLVardef@1d48e2d_HPS_FORMAT_FIGEXP M_FIG C_FIG Graphical Overview: Native and engineered human megakaryocytic extracellular vesicles (huMkEVs) for provide targeted non-viral cargo delivery to blood stem cells. We demonstrate that huMkEVs as a transformational cargo-delivery system to blood stem cells (hematopoietic stem and progenitor cells, HSPCs) in NOD-scid IL2R{gamma}null (NSG) mice. Intravenous delivery of native huMkEVs enhances de novo platelet biogenesis by inducing megakaryocytic differentiation of murine HSPCs, thus demonstrating the desirable strong tropism of huMkEVs for murine HSPCs. Based on this tropism, we demonstrate that engineered huMkEVs can deliver functional plasmid-DNA cargo specifically to HSPCs.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Cytotherapy
14 papers in training set
Top 0.1%
17.5%
2
Journal of Thrombosis and Haemostasis
28 papers in training set
Top 0.1%
6.4%
3
Bioengineering & Translational Medicine
21 papers in training set
Top 0.1%
6.4%
4
Journal of Controlled Release
39 papers in training set
Top 0.2%
4.8%
5
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 0.3%
4.8%
6
Nature Communications
4913 papers in training set
Top 38%
3.7%
7
Molecular Pharmaceutics
16 papers in training set
Top 0.1%
3.6%
8
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.2%
2.4%
9
Small
70 papers in training set
Top 0.3%
2.1%
50% of probability mass above
10
Cell Reports Methods
141 papers in training set
Top 2%
2.1%
11
Journal of Extracellular Vesicles
50 papers in training set
Top 0.1%
1.9%
12
Biomaterials
78 papers in training set
Top 0.5%
1.7%
13
Nano Letters
63 papers in training set
Top 2%
1.7%
14
Advanced Science
249 papers in training set
Top 11%
1.7%
15
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
16
Advanced Therapeutics
15 papers in training set
Top 0.2%
1.5%
17
Advanced Functional Materials
41 papers in training set
Top 1%
1.5%
18
Stem Cells Translational Medicine
11 papers in training set
Top 0.1%
1.1%
19
Journal of Extracellular Biology
18 papers in training set
Top 0.1%
0.9%
20
Nature Biomedical Engineering
42 papers in training set
Top 1%
0.9%
21
Fluids and Barriers of the CNS
21 papers in training set
Top 0.2%
0.9%
22
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 40%
0.9%
23
PLOS ONE
4510 papers in training set
Top 64%
0.9%
24
Advanced Healthcare Materials
71 papers in training set
Top 1%
0.9%
25
Circulation
66 papers in training set
Top 2%
0.8%
26
Molecular Therapy
71 papers in training set
Top 3%
0.8%
27
Bioactive Materials
18 papers in training set
Top 0.7%
0.7%
28
EMBO Molecular Medicine
85 papers in training set
Top 4%
0.7%
29
Advanced Materials
53 papers in training set
Top 2%
0.7%
30
Communications Biology
886 papers in training set
Top 26%
0.7%